We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CDXS market cap is 429.68M. The company's latest EPS is USD -0.9369 and P/E is -5.64.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 9.28M | 26.56M | 17.07M | 7.98M | 12.83M |
Operating Income | -22.08M | -519k | -11.89M | -22.73M | -16.39M |
Net Income | -34.91M | -7.19M | -11.51M | -22.76M | -20.64M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 68.46M | 69.06M | 104.75M | 138.59M | 70.14M |
Operating Income | -12.55M | -23.92M | -22.7M | -34.88M | -58.89M |
Net Income | -11.94M | -24.01M | -21.28M | -33.59M | -76.24M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 154.46M | 136.56M | 149.56M | 132.01M | 148.18M |
Total Liabilities | 62.95M | 49.95M | 70.29M | 70.56M | 74.78M |
Total Equity | 91.51M | 86.62M | 79.27M | 61.45M | 73.4M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 149.07M | 221.65M | 246.38M | 250.39M | 136.56M |
Total Liabilities | 43.56M | 51.54M | 81.99M | 105.6M | 49.95M |
Total Equity | 105.52M | 170.1M | 164.39M | 144.8M | 86.62M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -41.6M | -52.64M | -7.79M | -19.96M | -32.94M |
Investing | -5.96M | -4.86M | -28.56M | -55.65M | -54.12M |
Financing | 8.17M | 8.17M | 29.28M | 29.08M | 59.39M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -12.56M | -16.46M | -14.27M | 11.28M | -52.64M |
Investing | -3.67M | -5.75M | -21.42M | -13.58M | -4.86M |
Financing | 53.96M | 80.81M | 3.77M | -575k | 8.17M |
Market Cap | 429.68M |
Price to Earnings Ratio | -5.64 |
Price to Sales Ratio | 6.13 |
Price to Cash Ratio | 6.6 |
Price to Book Ratio | 4.96 |
Dividend Yield | - |
Shares Outstanding | 81.38M |
Average Volume (1 week) | 873.57k |
Average Volume (1 Month) | 747.71k |
52 Week Change | 71.99% |
52 Week High | 6.08 |
52 Week Low | 2.53 |
Spread (Intraday) | 0.8 (14.04%) |
Company Name | Codexis Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.codexis.com |
Industry | industrial organic chemicals (2860) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions